Basic Materials / Specialty ChemicalsJakartaID
$92.00
+1.00 (+1.10%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-2.1B · quality 41.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$214.2B
P/E
N/A
•EV/EBITDA
N/A
•ROE
0.2%
↑Gross Margin
24.4%
↑Debt/Equity
0.45
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2020–2025 · 5 años de histórico normalizado
Revenue CAGR
+18.8%
FCF CAGR
—
FCF margin
0.5%
FCF / Net income
4.40x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $219.02B · net income $255.9M · FCF $1.13B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | $219.02B | $219.02B | $224.84B | $185.48B | $144.22B | $126.55B | $92.65B |
| Net Income | $255.9M | $255.9M | $5.03B | $3.12B | $5.97B | $4.98B | $3.60B |
| EBITDA | $12.53B | $12.53B | $13.08B | $9.22B | $12.05B | $11.14B | $9.28B |
| EPS | 0.11 | 0.11 | 2.16 | 1.68 | 3.20 | 2.67 | 1.93 |
| Gross Margin | 24.4% | 24.4% | 25.0% | 24.6% | 24.2% | 23.9% | 23.3% |
| Operating Margin | 4.3% | 4.3% | 4.8% | 4.4% | 8.0% | 7.5% | 9.0% |
| Net Margin | 0.1% | 0.1% | 2.2% | 1.7% | 4.1% | 3.9% | 3.9% |
| Balance Sheet | |||||||
| Debt/Equity | 0.45 | 0.45 | 0.65 | 0.96 | 1.62 | 2.66 | 7.17 |
| Current Ratio | 1.87 | 1.87 | 1.86 | 1.17 | 1.27 | 1.28 | 1.12 |
| Cash Flow | |||||||
| Free Cash Flow | $1.13B | $1.13B | $-47.50B | $-2.08B | $256.6M | $3.04B | $-2.49B |
| Returns | |||||||
| ROE | 0.2% | 0.2% | 4.7% | 13.3% | 41.5% | 59.9% | 107.6% |
| Growth & Yield | |||||||
| Revenue Growth | -2.6% | -2.6% | 21.2% | 28.6% | 14.0% | 36.6% | — |
| EPS Growth | -94.9% | -94.9% | 28.7% | -47.6% | 19.9% | 38.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
320.4%
EPS terminal req.
$8.16
Spread vs growth
-415.3%
5Y implied EPS CAGR
145.9%
EPS terminal req.
$9.88
Spread vs growth
-240.8%
10Y implied EPS CAGR
64.5%
EPS terminal req.
$15.91
Spread vs growth
-159.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-25.2%
Start / end P/E
57.0x → 837.1x
EPS bridge
2.16 → 0.11
Residual
-1299.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.